Cara Therapeutics Inc

CARA:NASDAQ
RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 01/22/21 EST
19.15UNCH (UNCH)
Volume
17,408
Close
19.15quote price arrow up+0.17 (+0.90%)
Volume
459,728
52 week range
8.88 - 21.64

...

Loading . . .

KEY STATS

  • Open18.68
  • Day High19.23
  • Day Low18.18
  • Prev Close18.98
  • 52 Week High21.64
  • 52 Week High Date01/20/21
  • 52 Week Low8.88
  • 52 Week Low Date03/18/20
  • Market Cap954.24M
  • Shares Out49.83M
  • 10 Day Average Volume0.57M
  • Dividend-
  • Dividend Yield-
  • Beta1.51
  • 1 Year % Change17.2

RATIOS/PROFITABILITY

  • EPS (TTM)-2.12
  • P/E (TTM)-9.04
  • Fwd P/E (NTM)-15.79
  • EBITDA (MRQ)-102.68M
  • ROE (MRQ)-58.34%
  • Revenue (MRQ)27.50M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-360.35%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date03/09/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Cara Therapeutics Inc News

There is no recent news for this security.

Latest CARA News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Cara Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing chemical entities designed to alleviate pain and pruritus by focusing on kappa opioid receptors. It is developing a class of product candidates that target the body's peripheral nervous system. The Company operates through the activities related to the discovery and development of therapeutics to treat serious medical conditions, including pain and...
Derek Chalmers Ph.D.
President
Thomas Reilly
Chief Financial Officer
Richard Makara
Vice President
Address
4 Stamford Plz
Stamford, CT
06902-3834
United States